These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12623323)

  • 1. Antibacterial activity and endotoxin-binding capacity of Actisorb Silver 220.
    Müller G; Winkler Y; Kramer A
    J Hosp Infect; 2003 Mar; 53(3):211-4. PubMed ID: 12623323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wound management in an era of increasing bacterial antibiotic resistance: a role for topical silver treatment.
    Wright JB; Lam K; Burrell RE
    Am J Infect Control; 1998 Dec; 26(6):572-7. PubMed ID: 9836841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silver is still confusing.
    Hurlow J
    Ostomy Wound Manage; 2006 Apr; 52(4):14; author reply 14, 16, 18. PubMed ID: 16700115
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of honey compared to silver sulfadiazine for the treatment of burns: A systematic review of randomized controlled trials.
    Aziz Z; Abdul Rasool Hassan B
    Burns; 2017 Feb; 43(1):50-57. PubMed ID: 27576926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a honey based gel and silver sulphadiazine on bacterial infections of in vitro burn wounds.
    Boekema BK; Pool L; Ulrich MM
    Burns; 2013 Jun; 39(4):754-9. PubMed ID: 23036845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment and management of wound infection: the role of silver.
    Stephen-Haynes J; Toner L
    Br J Community Nurs; 2007 Mar; 12(3):S6, S8, S10-2. PubMed ID: 17505354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of antimicrobial activity of selected, commercially available wound dressing materials.
    Szweda P; Gorczyca G; Tylingo R
    J Wound Care; 2018 May; 27(5):320-326. PubMed ID: 29738292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the effectiveness of silver-coated dressing, chlorhexidine acetate (0.5%), citric acid (3%), and silver sulfadiazine (1%) for topical antibacterial effects against the multi-drug resistant Pseudomonas aeruginosa infecting full-skin thickness burn wounds on rats.
    Yabanoglu H; Basaran O; Aydogan C; Azap OK; Karakayali F; Moray G
    Int Surg; 2013; 98(4):416-23. PubMed ID: 24229034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEG site infections: a novel use for Actisorb Silver 220.
    Leak K
    Br J Community Nurs; 2002 Jun; 7(6):321-5. PubMed ID: 12066067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of wound infections using a bilayer chitosan wound dressing with sustainable antibiotic delivery.
    Mi FL; Wu YB; Shyu SS; Schoung JY; Huang YB; Tsai YH; Hao JY
    J Biomed Mater Res; 2002 Mar; 59(3):438-49. PubMed ID: 11774301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the use of silver in wound care: facts and fallacies.
    Lansdown AB
    Br J Nurs; 2004 Mar; 13(6 Suppl):S6-19. PubMed ID: 15126971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding Pseudomonas aeruginosa.
    Reynolds P
    Nurs Times; 2000 Jun; 96(23 Suppl):6-8. PubMed ID: 11963422
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of Urgotul SSD to reduce bacteria and promote healing in chronic wounds.
    Downe A
    Br J Community Nurs; 2013 Mar; Suppl():S32, S34-8. PubMed ID: 23682500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of silver-containing antimicrobial dressings and drugs.
    Castellano JJ; Shafii SM; Ko F; Donate G; Wright TE; Mannari RJ; Payne WG; Smith DJ; Robson MC
    Int Wound J; 2007 Jun; 4(2):114-22. PubMed ID: 17651227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experiences of using a silver hydroalginate dressing in Austria, Switzerland and Germany.
    Kammerlander G; Afarideh R; Baumgartner A; Berger M; Fischelmayer K; Hirschberger G; Hangler W; Huber A; Kramml M; Locherer E; Scandella C; Süss-Burkhard A; Wipplinger P
    J Wound Care; 2008 Sep; 17(9):384, 386-8. PubMed ID: 18833896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ability of a colloidal silver gel wound dressing to kill bacteria in vitro and in vivo.
    Tran PL; Huynh E; Hamood AN; de Souza A; Mehta D; Moeller KW; Moeller CD; Morgan M; Reid TW
    J Wound Care; 2017 Apr; 26(sup4):S16-S24. PubMed ID: 28379105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Pseudomonas aeruginosa biofilm-infected wounds with clinical wound care strategies: a quantitative study using an in vivo rabbit ear model.
    Seth AK; Geringer MR; Gurjala AN; Hong SJ; Galiano RD; Leung KP; Mustoe TA
    Plast Reconstr Surg; 2012 Feb; 129(2):262e-274e. PubMed ID: 22286442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial activity of Pakistani Beri honey compared with silver sulfadiazine on infected wounds: a clinical trial.
    Yousaf I; Ishaq I; Hussain MB; Inaam S; Saleem S; Qamar MU
    J Wound Care; 2019 May; 28(5):291-296. PubMed ID: 31067161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing.
    Yin HQ; Langford R; Burrell RE
    J Burn Care Rehabil; 1999; 20(3):195-200. PubMed ID: 10342470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a novel, antimicrobial dressing on in vivo, Pseudomonas aeruginosa wound biofilm: quantitative comparative analysis using a rabbit ear model.
    Seth AK; Zhong A; Nguyen KT; Hong SJ; Leung KP; Galiano RD; Mustoe TA
    Wound Repair Regen; 2014; 22(6):712-9. PubMed ID: 25230854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.